Norway· NO-ID_9F4C4BED-E71A-4E84-8707-9A5F782DA851
Elahere
A mirvetuximab soravtansine product containing mirvetuximab soravtansine, registered in Norway by AbbVie Deutschland GmbH & Co. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Mirvetuximab soravtansine is registered in 13 of 19 countries.
Countries holding a registration under ATC L01FX26 (mirvetuximab soravtansine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Mirvetuximab soravtansine · ATC L01FX26
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Mirvetuximab Soravtansine
- Manufacturer
- AbbVie Deutschland GmbH & Co
- Country
- Norway (NO)
- ATC code
- L01FX26
- ATC class
- Mirvetuximab soravtansine
- Defined daily dose
- 18 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_9F4C4BED-E71A-4E84-8707-9A5F782DA851
- no_varenummer43370420NOK 44431.6
- gtin8054083028835
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mirvetuximab soravtansine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumElahere 5 mg/mlAbbVie Deutschland
- CzechiaELAHEREAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- FinlandELAHEREAbbVie Deutschland GmbH&Co.KG
- IrelandELAHERE 5 mg/mL concentrate for solution for infusionImmunogen Biopharma (Ireland) Limited
- IcelandELAHEREAbbVie Deutschland GmbH & Co. KG
- PolandElahereAbbVie Deutschland GmbH & Co. KG
- SwedenELAHERE 5 mg/ml Koncentrat till infusionsvätska, lösningAbbVie Deutschland GmbH & Co KG
- SwitzerlandElahere
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Elahere
- Iceland · Elahere
- Liechtenstein · Elahere
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa1edd4a-34d3-4906-9698-dc9bb9de6ef1 GET /v1/drugs/aa1edd4a-34d3-4906-9698-dc9bb9de6ef1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Mirvetuksimabsoravtansin",
"merkevare_id": "ID_9F4C4BED-E71A-4E84-8707-9A5F782DA851",
"name_form_strength": "Elahere kons til inf oppl 5 mg/ml",
"prescription_group": "C"
}See everything about mirvetuximab soravtansine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.